320
Participants
Start Date
September 30, 2012
Primary Completion Date
August 31, 2014
Study Completion Date
February 28, 2015
Dapagliflozin
Tablets, Oral, 10 mg, Once daily, Up to 52 weeks
Placebo matching with Dapagliflozin
Tablets, Oral, 0 mg, Once daily, Up to 52 weeks
Saxagliptin
Tablets, Oral, 5 mg, Once daily, Up to 52 weeks
Metformin immediate release (IR)
Tablets, Oral, ≥ 1500 mg, Twice daily, Up to 52 weeks
Local Institution, Aguascalientes
Tidewater Integrated Medical Research, Virginia Beach
Metrolina Internal Medicine, Charlotte
Compass Research East, Llc, Oviedo
Omega Research Consultants, Llc, Orlando
Palm Springs Research Institute, Hialeah
International Research Associates, Llc, Miami
Palm Harbor Medical Associates, Palm Harbor
Fpa Clinical Research, Kissimmee
University Of Alabama At Birmingham, Birmingham
Jackson Clinic, Rolling Fork
Local Institution, Guadalajara
Local Institution, Zapopan
Local Institution, Zapopan
Sterling Research Grp, Ltd., Cincinnati
Clinical Research Advantage, Evansville
Associated Internal Medicine Specialists, Battle Creek
Cedar Crosse Research Center, Chicago
Local Institution, Monterrey
Local Institution, Monterrey
Arkansas Clinical Research, Little Rock
Endocrine Associates, Houston
Sam Clinical Research Center, San Antonio
Clinical Research Advantage, Inc., Phoenix
Elite Clinical Studies, Llc, Phoenix
Clinical Research Advantage Inc/Desert Clinical Research Llc, Mesa
Randall G. Shue, Do, Inc., Los Angeles
National Research Institute, Los Angeles
Torrance Clinical Research Institute Inc., Lomita
Diabetes Medical Center Of California, Northridge
Cassidy Medical Group/Clinical Research Advantage, Vista
Local Institution, Ploieşti
Local Institution, Moscow
Local Institution, Yaroslaval
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Craiova
Local Institution, Kursk
Local Institution, Galati
Local Institution, Constanța
Premier Research, Trenton
Local Institution, Broumov
Local Institution, Pardubice
Local Institution, Prague
Local Institution, Prague
Local Institution, Pribram V
Local Institution, Bialystok
Local Institution, Krakow
Local Institution, Ruda Śląska
Local Institution, Warsaw
Local Institution, Warsaw
Local Institution, Warsaw
Local Institution, Żory
Clinical Research Puerto Rico, San Juan
Local Institution, Bucharest
Local Institution, Bucharest
Local Institution, Portsmouth
Local Institution, Newport
Local Institution, Liverpool
Local Institution, Chippenham
Local Institution, Bedfordshire
Local Institution, London
Lead Sponsor
AstraZeneca
INDUSTRY